Illness	Number of cases
Hyperplasia of prostate (N40)	225
Malignant neoplasm of prostate (C61)	212
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	190
Calculus of kidney and ureter - Calculus of kidney (N20.0)	140
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	126
Calculus of kidney and ureter - Calculus of ureter (N20.1)	119
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	97
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5)	94
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9)	88
Obstructive and reflux uropathy (N13.3)	76

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	744
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	732
(1-999.40)	575
Insertion, exchange or removal of a ureteral stent (8-137.10)	466
Insertion, exchange or removal of a ureteral stent (8-137.00)	376
Use of an imaging procedure during an operation (3-992)	263
Examination of the urethra and the urinary bladder by endoscopy (1-661)	262
(8-137.20)	244
(9-984.7)	232
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1)	211

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Koronare Herzkrankheit (KHK)

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ25
CQ03
CQ28

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
241	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
234	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
216	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB07	Surgical technical assistant (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)
HB16	Dietician (m/f)	Beteiligung an der berufspraktischen Ausbildung
HB17	Auxiliary nurse (m/f)
HB18	Emergency paramedics (m/f) (training period 3 years)
HB19	Nursing professionals